TBIO — Telesis Bio Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.07m
- $1.97m
- $27.51m
Brief: Telesis Bio And Cellibre Announce Collaboration To Optimize Development Of Future Bioxp Dbc Instrument
Brief: Codex Dna Announces Plan To Change Corporate Name To Telesis Bio
Codex DNA Inc reports results for the quarter ended in June - Earnings Summary
Brief: Codex DNA Reports Q2 Loss Per Share $0.50
Brief: Codex DNA Files For Mixed Shelf Of Up To $100 Million – SEC Filing
Brief: Codex DNA Says Board Approved The Expansion Of The Board From Six To Seven Members
Brief: Codex DNA - Jennifer Mcnealey Provided Notice Of Intent To Resign As CFO
Brief: Codex DNA Demonstrates End-to-End Workflow for Storing, Retrieving Data in Synthetic DNA
Brief: Codex Dna Reports Fourth Quarter And Full Year 2021 Financial Results
U.S. STOCKS ON THE MOVE-Tilray, Moderna, Novavax, WeWork, Big Tech
U.S. STOCKS ON THE MOVE-Tesla, Dell, Citi Trends, Tilly's, Century Therapeutics
U.S. STOCKS ON THE MOVE-Bank stocks, Robinhood, Cardinal Health, Infosys, Zynga
Beam Therapeutics, Codex DNA rise on Pfizer partnership
Pfizer CEO unsure on need for fourth dose of COVID-19 vaccine (updated)
Codex DNA jumps on deal with Pfizer
Brief: Codex DNA Signs Early Access Collaboration And Licensing Agreement With Pfizer
U.S. STOCKS ON THE MOVE-Calix, Codex DNA, Victoria's Secret
Codex DNA rises on research and license deal with Pfizer
Brief: Codex Dna Inc - On Dec 22, 2021, Co Entered Into Research Collaboration And License Agreement With Pfizer Inc